Significances of the Early Diagnosis Using High Sensitivity Troponin I Combined with H-FABP in Non-ST Segment Elevation Acute Coronary Syndrome

QIU Jiang

PDF(952 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(952 KB)
Labeled Immunoassays and Clinical Medicine ›› 2021, Vol. 28 ›› Issue (2) : 240-242. DOI: 10.11748/bjmy.issn.1006-1703.2021.02.015
Clinical Investigation

Significances of the Early Diagnosis Using High Sensitivity Troponin I Combined with H-FABP in Non-ST Segment Elevation Acute Coronary Syndrome

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 28(2): 240-242 https://doi.org/10.11748/bjmy.issn.1006-1703.2021.02.015

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(952 KB)

Accesses

Citation

Detail

Sections
Recommended

/